These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28162016)

  • 1. Proteomic studies associated with Parkinson's disease.
    Kasap M; Akpinar G; Kanli A
    Expert Rev Proteomics; 2017 Mar; 14(3):193-209. PubMed ID: 28162016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.
    Ren R; Sun Y; Zhao X; Pu X
    Clin Chem Lab Med; 2015 Sep; 53(10):1495-506. PubMed ID: 25581757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
    Singh MP; Patel S; Dikshit M; Gupta YK
    Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G; Singh K; Tiwari MN; Singh MP
    Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease.
    Chin MH; Qian WJ; Wang H; Petyuk VA; Bloom JS; Sforza DM; Laćan G; Liu D; Khan AH; Cantor RM; Bigelow DJ; Melega WP; Camp DG; Smith RD; Smith DJ
    J Proteome Res; 2008 Feb; 7(2):666-77. PubMed ID: 18173235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
    Redenšek S; Dolžan V; Kunej T
    OMICS; 2018 Jan; 22(1):1-16. PubMed ID: 29356624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson's Disease: A Systematic Review.
    Rike WA; Stern S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.
    Dixit A; Mehta R; Singh AK
    Cell Mol Neurobiol; 2019 Oct; 39(7):901-915. PubMed ID: 31190159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in animal models of Alzheimer's and Parkinson's diseases.
    Sowell RA; Owen JB; Butterfield DA
    Ageing Res Rev; 2009 Jan; 8(1):1-17. PubMed ID: 18703168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A systematic review of proteomics studies.
    Chelliah SS; Bhuvanendran S; Magalingam KB; Kamarudin MNA; Radhakrishnan AK
    Ageing Res Rev; 2022 Jan; 73():101514. PubMed ID: 34798300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis.
    Alberio T; Bondi H; Colombo F; Alloggio I; Pieroni L; Urbani A; Fasano M
    Mol Biosyst; 2014 Jun; 10(6):1332-44. PubMed ID: 24675778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights on the mitochondrial proteome plasticity in Parkinson's disease.
    Aroso M; Ferreira R; Freitas A; Vitorino R; Gomez-Lazaro M
    Proteomics Clin Appl; 2016 Apr; 10(4):416-29. PubMed ID: 26749507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease.
    Krishna A; Biryukov M; Trefois C; Antony PM; Hussong R; Lin J; Heinäniemi M; Glusman G; Köglsberger S; Boyd O; van den Berg BH; Linke D; Huang D; Wang K; Hood L; Tholey A; Schneider R; Galas DJ; Balling R; May P
    BMC Genomics; 2014 Dec; 15(1):1154. PubMed ID: 25528190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.
    Licker V; Turck N; Kövari E; Burkhardt K; Côte M; Surini-Demiri M; Lobrinus JA; Sanchez JC; Burkhard PR
    Proteomics; 2014 Mar; 14(6):784-94. PubMed ID: 24449343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics in human Parkinson's disease research.
    Licker V; Kövari E; Hochstrasser DF; Burkhard PR
    J Proteomics; 2009 Nov; 73(1):10-29. PubMed ID: 19632367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomic biomarkers in Parkinson's disease].
    Bandrés S; Durán R; Barrero F; Ramírez M; Vives F
    Rev Neurol; 2014 Feb; 58(4):166-74. PubMed ID: 24504879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.